Unified Patent Court (UPC) analytics are now available. Check here

Get Patent Opposition Report for Mylan

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Mylan against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2653873Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAJul 20, 2022
EP2785702Crystalline Dapagliflozin HydrateSANDOZOct 22, 2020
EP2371361Methods To Mobilize Progenitor/Stem CellsGENZYMEMay 4, 2020
EP2630962Low Frequency Glatiramer Acetate TherapyYEDA RESEARCHMar 25, 2019
EP3199172Dosing Regimen For Multiple SclerosisYEDA RESEARCHMar 25, 2019
EP2420223Aqueous Pharmaceutical Compositions Containing Borate-Polyol ComplexesALCON RESEARCHApr 19, 2018
EP3000810N3 Alkylated Benzimidazole Derivative As Mek InhibitorARRAY BIOPHARMAApr 19, 2018
EP2308466Aqueous Pharmaceutical Compositions Containing Borate-Polyol ComplexesALCON RESEARCHFeb 28, 2018
EP3042646Pharmaceutical Compositions Having Desirable BioavailabilityALCON RESEARCHFeb 9, 2018
EP2599475Pharmaceutical Composition Having Desirable BioavailabilityALCON RESEARCHJan 26, 2018

Explore Mylan's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2299989Jan 2, 2019Stabilized Transdermal Drug Delivery System2
EP2702143Jun 6, 2018Methods For Reducing Accumulation Of Lactate During Culturing And Method For Producing Polypeptide1
EP2682388Jan 10, 2018Novel Polymorphic Forms Of Perindopril (L)-Arginine And Process For The Preparation Thereof2